Clinical Trials Sponsored by Jayme Baker

Total 2553 results

Bayer

Completed

Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers

Contraception

Finland, Estonia, Lithuania, Austria
Bayer

Completed

An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS (ABOVE)

Multiple Sclerosis, Relapsing-Remitting

United States, Canada
Bayer

Completed

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches

Cardiovascular Abnormalities
Bayer

Completed

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

Acne Vulgaris

United States
Bayer

Completed

Fat Distribution in Healthy Early Postmenopausal Women

Healthy | Postmenopause

Austria
Bayer

Completed

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

Healthy

Germany
Bayer

Completed

Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

Acne Vulgaris

United States
Bayer

Completed

BAY59-7939 Japanese in Atrial Fibrillation (2nd)

Atrial Fibrillation

Japan
Bayer

Completed

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

Lymphoma, B-Cell | Non-Hodgkin's Lymphoma | Lymphoma, Low-Grade

Japan
Bayer

Completed

A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy. (FINDER)

Erectile Dysfunction

Belgium, Finland, Germany, France, Denmark, United Kingdom, Spain
Bayer

Completed

BAY43-9006 Phase II Study for Renal Cell Carcinoma

Carcinoma, Renal Cell

Japan
Bayer

Completed

Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes

Heartburn

Germany
Bayer

Completed

Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 Hours

Erectile Dysfunction
Bayer

Completed

Extension Program for Bay 43-9006

Metastasis | Neoplasm

Canada, Belgium, Germany, United States
Bayer

Completed

Depression Related Improvement With Vardenafil for Erectile Response (DRIVER)

Depression | Erectile Dysfunction

Italy, Spain, France, United States, Canada
Bayer

Completed

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections

Urinary Tract Infection

United States
Bayer

Completed

BAY38-9456 - Pivotal Trial for Diabetes Patient

Diabetes Mellitus | Erectile Dysfunction
Bayer

Completed

Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma

Carcinoma, Renal Cell

Canada, United States, Germany, United Kingdom, France, Netherlands
Bayer

Completed

Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections) (DRAGON)

Infection, Intra-abdominal

China, Hong Kong, Indonesia, Korea, Republic of, Malaysia, Taiwan
Bayer

Terminated

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

Hemophilia A

United States
Bayer

Completed

Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia

Erectile Dysfunction

Hong Kong, Malaysia, Singapore, Thailand, Philippines, Indonesia
Bayer

Completed

Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia

Pneumonia

Belgium, Germany, Spain, Greece, France, Netherlands, Chile, Mexico, Poland, South Africa, United Kingdom, Argentina, Colombia, Israel, Lithuania, Peru, Portugal, Sweden
Bayer

Completed

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Hypertension | Postmenopause
Bayer

Completed

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

Brain Neoplasms

Japan
Bayer

Completed

Vardenafil in Tinnitus

Tinnitus

Germany
Bayer

Completed

Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

Wound Healing | Gene Expression | Cell Proliferation

Germany
Bayer

Completed

Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.

Hypertension

Italy, Spain
Bayer

Completed

Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold

Common Cold

United Kingdom
Bayer

Completed

Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis

Chronic Bronchitis

Spain, China, Argentina, Germany, Greece, Portugal, Canada, Netherlands, Australia, Peru, Philippines, Belgium, Switzerland, Chile, Italy, Thailand, Mexico, Lithuania, South Africa, Croatia, France, Colombia, Indonesia, Latvia, Hong Kong, United Kingdom and more
Bayer

Completed

Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980

Hemophilia A

United States
Bayer

Completed

Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients

Neoplasms

United States
Bayer

Completed

Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors

Erectile Dysfunction

Spain, Italy, Netherlands, Finland, Germany, France, Sweden
Bayer

Completed

Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

Uterine Hemorrhage

Ireland, Denmark, Norway
Bayer

Completed

Health Economic Evaluation of Primovist-enhanced Liver MRI

Neoplasm Metastasis | Colorectal Neoplasms

Germany, Spain, Sweden, Switzerland, Italy, Korea, Republic of, Austria, Thailand, Netherlands
Bayer

Terminated

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small Cell Lung

Belgium, Italy, Spain, Hong Kong, United States, Germany, United Kingdom, Chile, Taiwan, Australia, Canada, Argentina, Puerto Rico, France, Poland, Russian Federation, Sweden, Hungary, Netherlands, Brazil, Korea, Republic of
Bayer

Completed

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. (RECORD 4)

Venous Thromboembolism

Poland, United States, India, Denmark, Canada, Sweden, Bulgaria, Israel, Lithuania, Norway, Pakistan, Mexico, Sri Lanka
Bayer

Completed

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

Contraception

Netherlands, Germany
Bayer

Completed

A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

Pneumonia

Italy
Bayer

Completed

Hepatic Impairment Study

Liver Disease

United States
Bayer

Completed

BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma

Carcinoma, Renal Cell

Russian Federation, France, United States, Germany, Poland, Ukraine, United Kingdom
Bayer

Completed

Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.

Atrial Fibrillation

Germany
Bayer

Completed

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (ODIXaHIP-OD)

Venous Thromboembolism

Italy, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, Norway, United Kingdom, France
Bayer

Completed

Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Venous Thromboembolism

Italy, Spain, Poland, United States, Czech Republic, Canada, Denmark, Netherlands, Belgium, Chile, Slovakia, Hungary, Austria, France, Germany, South Africa, Sweden, Turkey, Colombia, Israel, Mexico, Argentina, Norway, Brazil, Lithuania, ... and more
Bayer

Completed

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

Contraception

France, Italy, Spain, Germany, United Kingdom
Bayer

Completed

Copanlisib Mass Balance Study

Healthy Volunteers

Netherlands
Bayer

Completed

Special Drug Use Investigation of Glucobay OD

Diabetes Mellitus

Japan
Bayer

Completed

Validation Study for Endometriosis PRO (VALEPRO)

Endometriosis

United States, Germany
Bayer

Completed

ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer

Metastatic Breast Cancer

Spain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
Bayer

Completed

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration (REVIEW)

Macular Degeneration

Portugal
Bayer

Terminated

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors

Neoplasms

Netherlands

3

Subscribe